three moieties were altered by the same mutation, the presumption was that the three genes were identical. The occurrence of this mutant strain provides an opportunity to examine the relationship between different phenomena coded for by I region genes--in particular to determine whether Ir genes and genes coding for the Ia specificities are the same. We have therefore examined the response to several defined antigens: poly(LTyr, LGlu)-poly(DLAla) , and to the male-specific H-Y antigen--all antigens being totally or partially under control of/r genes mapping in the I-A subregion (3, 4) . In brief, the antibody responses to the synthetic polypeptide antigens were the same in C57BL/6 and in bm 12; by contrast, bml2 female mice were unable to generate cytotoxic T cells (Tc) in response to the male H-Y antigen, whereas C57BL/6 females reproducibly made a good response.
Materials and Methods
To generate anti-H-Y cytotoxic cells, female mice were primed by an intraperitoneal injection of 10 r male spleen cells (in 0.2 ml phosphate-buffered saline [PBS] ), then boosted in vitro 2 wk-2 mo later (4, 5) . Spleen cells (10 s) from primed female mice were stimulated with x-irradiated (1,500 rad) male spleen cells in 20 ml culture medium in upright Costar 3050 flasks (Costar, Data Packaging, Cambridge, Mass.) for 5 d at 37°C in a humidified 10% CO2 atmosphere. The culture medium consisted of RPMI-1640 medium (Flow Laboratories, Inc., Rockville, Md.), supplemented with 2% heat-inactivated human serum, 20-raM Hepes buffer, 2 mM L-glutamine, 100 pg/ml streptomycin, 100 IU/ml penicillin, and 5 × 10 -5 M 2-mereaptoethanol. Target cells used in the cell-mediated lysis (CML) assay were prepared by stimulating spleen cells (5 × 106/ml) with 2/~g/ml concanavalin A (ConA) (Pharmaeia Fine Chemicals, Uppsala, Sweden) in 50 ml of culture medium in 75-cm 2 flasks (Lux Scientific Corp., Newbury Park, Calif.). After an incubation time of 2 d at 37°C in 10% CO2, the blast cells were isolated on Ficoll-Paque (1.077 g/ml), washed twice, and resuspended in RPMI-1640 medium with 10% fetal calf serum (FCS). 10 e target cells in 0.5 mi RPMI-FCS were labeled with 300/tCi Naz[SLCr]O4 (Radiochemical Centre, Amersham, England) for 90 min at 37°C, then washed three times, and resuspended to 2 × 105/ml. For the CML assay, Tc generated in vitro were harvested, washed twice, and resuspended in RPMI-FCS. Graded numbers of Tc in 100 pl were mixed with 100/d of target cells (2 × 104) in round-bottomed Cooke microtiter plates (Cooke Engineering Co., Alexandria, Va.). After a 4-h incubation at 37°C in 10% CO2, 100 /d of the supernate was harvested from each well and the radioactivity measured in a gamma counter (Packard Instrument Co., Inc., Downers Grove, Ill.). All experiments were set up in triplicate. The specific 5~Cr release was calculated as: percent 5aCr release of test -percent spontaneous release percent specific release = percent maximum release -percent spontaneous release
The spontaneous and maximum 5aCr release were determined by incubating target cells with medium or 1% Nonidet P-40, respectively.
The antibody responses of the parental C57BL/6 and the mutant bm 12 mice were examined by immunizing mice with 10 #g/ml (T,G)-A--L, (Phe,G)-A--L, and (H,G)-A--L (Miles-Yeda Ltd., Rehovot, Israel) in Freund's adjuvant (6, 7) . Individual mice were bled and tested in an indirect antibody binding radioiummune assay for antibody activity. Polyvinylchloride plates (Cooke Engineering Co.) were coated with 25/tl of antigen (at 100/.tg/ml in PBS) at room temperature for 1 h, after which the plates were washed four times with PBS that contained 2% bovine serum albumin and 0.06% sodium azide. Doubling dilutions of 25/~1 of antiserum were added to the plates, and these were incubated at 37°C for 1 h, then at 4°C overnight, and subsequently washed four times. II2~-protein A (Pharmacia Fine Chemicals) in 25 pl was added to each well, the plates incubated for 1 h at 4°C, washed five times, dried, and then cut using a hot wire. The individual wells were counted for radioactivity. Protein-A was iodinated by the chloramine T method.
Results

Antibody Response to (T,G)-A--L, (Phe, G)-A--L, and (H,G)-A--L. Groups of 5-10
mice were immunized with the above-mentioned antigens and their antibody response measured by the protein-A binding assay. The results are shown in Table I for bm 12, C57BL/6, and an appropriate responder or nonresponder strain for each antigen. With (T,G)-A--L, both C57BL/6 and bml2 showed a high response with mean titers of 1:320 and 1:640, respectively. Similarly, both strains gave a high response to (Phe,G)-A--L, with mean titers of 1:256, for C57BL/6 and 1:432, for bm 12. Neither C57BL/6 nor bml2 showed any response to (H,G)-A--L (Table I ). There was clearly no difference in the response of C57BL/6 and bm 12 to any of the antigens.
Comparison of Tc to H-Y in C57BL/6 and bml2. C57BL/6 females produced an
effective cytotoxic response against male ConA blast cells (Fig. 1) , with 30% cell lysis at a 25:1 effector:target cell ratio; no lysis of C57BL/6 female cells was detected, indicating that the response was H-Y specific. By contrast, bm 12 females were unable to make any H-Y cytotoxic response, and the results of Fig. 1 have now been reproduced on several occasions. The defect lay in the ability of bm 12 to respond to H-Y and not in the expression of the antigen, as female C57BL/6 mice, primed with C57BL/6 male cells could also lyse bm 12 male cells and C57BL/6 male cells (Fig. 1) The titers were calculated as the dilution of serum which gave greater than or equal to four times the background counts (400 cpm). The background was ~90 cpm and the maximum cpm ranged from 8,000 to 26,000 in the different mice. The reciprocal titers are shown and the mean ± SEM in parentheses. NT, not tested. cells as described above. In addition, priming was also done by skin grafting, grafting plus lymphocyte injection and by cell injection into the footpads--all with the same result: bml2 was unable to generate Tc to the H-Y antigen.
Antibody Response to (T,G)-A--L, (Phe, G)-A--L, and (H,G)-A--L *
Antigen C57BL/6 B6.C-H-2 bm12 BI0.BR BI0.S (T,G)-A--L 80
Generation of Tc in an F1 Hybrid Using the Two Nonresponder Strains bm 12 and B I O.A.
As bm 12 was clearly a nonresponder to the H-Y antigen--a response which must now be considered to be influenced by Ia-1 gene, as this is the site of the mutation in bml2--we determined whether there were any circumstances under which bml2 could respond to the H-Y antigen, particularly as other studies had indicated the presence of complementary Ir genes for H-Y in several H-2 haplotypes. Thus, two nonresponder strains, bm 12 and B 10.A, were examined in the F1 hybrid for the generation of Tc to the H-Y antigen. Female F1 hybrid mice, primed in vivo and then stimulated in vitro with bml2 male cells, were able to lyse both bml2 and C57BL/6, but not B10.A male ConA blast cells (Fig. 2 A) . The response was specific for the H-Y antigen as bml2 female cells could not be lysed (Fig. 2 ). C57BL/6 and bml2 could be lysed as they share the appropriate associative target H-2 antigen--H-2D b in this case--with the priming cell. B 10.A (H-2Kk,D d) does not have the appropriate associative antigen and was not lysed (8, 9) , nor could it stimulate an anti-H-Y cytotoxic response in Fa female mice that had been primed with bml2 male cells (Fig. 2B ). The results demonstrate the presence of complementary Ir genes in bml2 and BI0.A.
Discussion
The results demonstrate, unequivocally, that a mutation in the Ia-1 gene in the/-A subregion has affected one immune response (Ir) gene, but has not affected those Ir genes responsible for the antibody response to (T,G)-A--L and (Phe,G)-A--L. Thus, the preliminary analysis has led us to conclude that the gene(s) coding for the Ia specificities (detected serologically) and at least one Ir gene may be the same, but that this does not apply to all/r genes and under all circumstances. The answer is yes, but with several qualifications: First, the immunizing dose should be considered, as sufficiently low doses of antigen are critical in demonstrating the presence of Ir genes (12) . Although it cannot be excluded that other doses of antigen may have given different results, the doses used could clearly differentiate between high and nonresponders for the three antigens used (Table I ). Secondly, it is possible that Ir gene products and Ia alloantigens are expressed on different sites of the one glycoprotein chain and the mutation has altered one site but not the other. This is possible, but unlikely as there appears to be a gross disturbance in the Ia-bearing chain, as demonstrated serologically, and biochemically with both alloantisera and xenoantisera (M. Sandrin, I. F. C. McKenzie, and R. W. Melvold. Manuscript in preparation.). In addition, the response to the H-Y antigen has been altered ( Fig. 1) . At this time, with the evidence presented herein (Table I) , we must conclude that the
Ia-1 and Ir-I[(T,G)-A--L],[Ir-(Phe,G)-A--L]
genes are separate structures. Whether this applies to other soluble polypeptide antigens is currently under investigation with a large series of antigens. By contrast to the foregoing, the immune response to H-Y is clearly altered in the bml2 mutant strain and at least for this antigen we can state that it is likely that Ir-H-Y and Ia-1 are the same. However, the immune response to the H-Y antigen is complex and different aspects of the immune response appear to be under separate (unrelated?) gene control. For example, skin graft rejection and delayed-type hypersensitivity responses are effected by a gene mapping in the I-B subregion ( [ 12] ; and F. Summary The B6.C-H-2 bin12 (bml2) strain has a mutation in the I-A subregion of the murine H-2 complex and is characterized by a loss of serologically detected Ia antigens and a strong graft rejection and mixed lymphocyte response between parent and mutant. It was presumed that the mutation affected the Ia-I gene and to determine the relationship of Ia antigens and Ir genes, the immune responses of mutant and parent were compared. The immune responses to poly(LTyr,LGlu)-poly(vLAla)--poly(LLys), poly(Phe,Glu)-poly(DLAla)--poly(LLys), and poly(His,Glu)-poly(DLAla)--poly(LLys) in parent and mutant were the same, indicating that Ia-i and the Ir genes for these antigens are not identical. By contrast, although C57BL/6 gave a good response, the mutant strain was unable to generate cytotoxic T lymphocytes to the male-specific H-Y antigen--a response under I-A subregion Ir gene control, which now must be considered to be the Ia-1 gene. In addition, complementary Ir genes in the //-2 b haplotype for the H-Y immune response could be detected when the bml2 mutant was used.
